Alantolactone

Alantolactone is a modulator of TGF-beta / Smad and STAT used in studies of JAK-STAT Signaling and TGF-beta / Smad Signaling. It is especially relevant in cancer, cell signaling, and developmental biology models, where defined compound exposure can be linked to cytokine-responsive transcriptional signaling and immune regulation and Smad-mediated transcription, differentiation, and fibrotic signaling.

By modulating TGF-beta / Smad and STAT, Alantolactone can be used to examine cytokine-responsive transcriptional signaling and immune regulation and Smad-mediated transcription, differentiation, and fibrotic signaling. The signaling pathway modulator annotation adds relevance to pathway-reporter and mechanistic-phenotyping studies, together with downstream-response mapping in the same experimental setting. In cancer, cell signaling, and developmental biology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving TGF-beta / Smad and STAT
• Pathway perturbation studies connected to JAK-STAT Signaling and TGF-beta / Smad Signaling
• Context-dependent response profiling and mechanism comparison
• Pathway-reporter and mechanistic-phenotyping studies

Overall, Alantolactone is appropriate when a defined chemical perturbant is needed to connect TGF-beta / Smad and STAT with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cell signaling, and developmental biology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.